# Qifeng Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qifeng-yang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,774 |
| Field | Breast Cancer Treatment Studies |
| h-index | 64 |
| i10-index | 274 |
| Last Known Institution | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| OpenAlex ID | https://openalex.org/A5016935464 |
| ORCID iD | https://orcid.org/0000-0003-0576-8513 |
| Works | 477 |

## Researcher papers

- [Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer](https://scholariq.org/papers/thio-glucose-bound-gold-nanoparticles-enhance-radio-cytotoxic-targeting-of/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Circular RNAs in diseases](https://scholariq.org/topics/circular-rnas-in-diseases/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Researcher university

- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.